143071-78-7 Usage
General Description
The chemical "6-(4-fluorophenoxy)pyridine-3-amine, 97+%" is a high purity compound that is composed of a pyridine ring with a fluorophenoxy group and an amine group attached. It is commonly used as a building block in the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals. With a purity level of 97% or higher, this compound is a reliable and high-quality component for chemical reactions and research purposes. Its specific structure and properties make it valuable for the development of various chemical compounds and materials.
Check Digit Verification of cas no
The CAS Registry Mumber 143071-78-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,3,0,7 and 1 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 143071-78:
(8*1)+(7*4)+(6*3)+(5*0)+(4*7)+(3*1)+(2*7)+(1*8)=107
107 % 10 = 7
So 143071-78-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H9FN2O/c12-8-1-4-10(5-2-8)15-11-6-3-9(13)7-14-11/h1-7H,13H2
143071-78-7Relevant articles and documents
AGRICULTURAL CHEMICALS
-
Page/Page column 59; 104, (2019/08/08)
The present invention relates to picolinic acid derivatives that are useful in treating fungal diseases ofplants.
INDAZOLE-3-CARBOXAMIDES AND THEIR USE AS WNT/B-CATENIN SIGNALING PATHWAY INHIBITORS
-
Paragraph 00291, (2013/03/28)
lndazole-3-carboxamide compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of an indazole-3- carboxamide compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.
